ILB-3101

· Innolake Biopharm

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ILB-3101, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the ILB-3101 in Patients with Advanced Solid Tumors [Phase 1]